Case Reports Showing a Long-Term Effect of Subanesthetic Ketamine Infusion in Reducing L-DOPA-Induced Dyskinesias

Case Reports Showing a Long-Term Effect of Subanesthetic Ketamine Infusion in Reducing L-DOPA-Induced Dyskinesias

Ketamine is an FDA-approved drug with a known safety profile. Low-dose subanesthetic intravenous ketamine infusion treatment has led to long-term reduction of treatment-resistant depression and of chronic pain states. We report on low-dose subanesthetic intravenous ketamine infusion treatment in Par...

Full description

Bibliographic Details
Main Authors: Scott J. Sherman, Miguel Estevez, Ari B. Magill, Torsten Falk
Format: Article
Language:English
Published: Karger Publishers 2016-02-01
Series:Case Reports in Neurology
Subjects:
Parkinson’s disease
Depression
Pain
Hypersynchrony
NMDA receptors
Levodopa
Online Access:http://www.karger.com/Article/FullText/444278

Internet

http://www.karger.com/Article/FullText/444278

Similar Items